QA: Anixa Biosciences Inc in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000715446_2020_Anixa_Biosciences_Inc.pdf

Logs

Graph

Absolute values for 0000715446, Anixa Biosciences Inc

  xvar xval
0 AssetsCurrent 6,093,124
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 200,569
3 remainder_Assets 0
4 LiabilitiesCurrent 1,481,315
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,662,828
9 ResearchAndDevelopmentExpense 5,473,427
10 remainder_Expenses 1,003,750
11 remainder_Revenues 250,000
12 remainder_NetIncome 71,353
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 6,293,693
1 Liabilities 1,481,315
2 Expenses 12,140,005
3 Revenues 250,000
4 StockholdersEquity 4,812,378
5 NetIncome -11,818,652
6 ComprehensiveNetIncome -11,818,652
7 BaseVar 10,118,183
8 EconomicCapitalRatio -0.911

Edgar->Model Mapping

Feature Distribution

Change over Time